The JAK3 expression results are consistent with the earlier assumptions that the increase in JAK3 protein expression takes place primarily in T lymphocytes, which mediate inflammatory reactions that play a key role in the etiopathogenesis of LP, as well as described PV and BP. The gene discussed is JAK3; the disease is acquired polycythemia vera.